Results 41 to 50 of about 289,325 (184)

Refractory Migraine: Mechanisms and Management

open access: yesRinsho Shinkeigaku, 2012
In spite of the numerous advances in headache diagnosis and treatment, refractory headache disorders remain a frontier of headache medicine. There are no fully-accepted definitions for this group of disorders, especially for refractory migraine (RM). The epidemiology and pathophysiology are poorly characterized, and consensus is lacking on approaches ...
openaire   +3 more sources

Genetic epilepsies with myoclonic seizures: Mechanisms and syndromes

open access: yesEpilepsia Open, EarlyView.
Abstract Genetic epilepsy with myoclonic seizures encompasses a heterogeneous spectrum of conditions, ranging from benign and self‐limiting forms to severe, progressive disorders. While their causes are diverse, a significant proportion stems from genetic abnormalities.
Antonietta Coppola   +3 more
wiley   +1 more source

Status epilepticus: Updates on mechanisms and treatments

open access: yesEpilepsia Open, EarlyView.
Abstract Status epilepticus (SE) consists of prolonged, self‐sustaining seizures and is a common neurological emergency that causes respiratory compromise and neuronal injury. Without prompt treatment, the seizures can become resistant to benzodiazepines, leading to the progressive evolution of established, refractory, and super‐refractory SE.
Suchitra Joshi, Jaideep Kapur
wiley   +1 more source

Advances in pharmaceutic managements of migraine

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2022
Migraine is a neurovascular disorder with great burden so that effective abortive and preventive treatment is needed. Different from the previous choice of drugs based on clinical experience, the specific treatment targeting the pathogenesis of migraine ...
LI Yan⁃sheng
doaj   +1 more source

Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers [PDF]

open access: yes, 2006
Sensitivity to light was investigated 5 and 8 h after consumption of an amino acid drink which contained L-tryptophan (balanced amino acid condition: 19 controls and 22 migraine sufferers) or which produced a short-term reduction in brain serotonin ...
Drummond, P.D.
core  

Botulinum Toxin for First Bite Syndrome: A Symptom‐Guided “Follow‐The‐Pain” Injection Strategy

open access: yesHead &Neck, EarlyView.
ABSTRACT Background To evaluate botulinum toxin type A (BoNT‐A) for First Bite Syndrome (FBS) and assess a symptom‐guided “Follow‐the‐Pain” (FTP) injection strategy in patients with incomplete response to standard treatment. Methods Consecutive patients with postoperative FBS were treated with ultrasound‐guided intraparotid BoNT‐A injection.
Rosario Marchese‐Ragona   +5 more
wiley   +1 more source

From cancer prevention to survivorship: Comprehensive menopause management after risk‐reducing salpingo‐oophorectomy

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Risk‐reducing salpingo‐oophorectomy (RRSO) is the cornerstone of ovarian cancer prevention for women with hereditary cancer predisposition syndromes. When performed before natural menopause, however, RRSO induces immediate surgical menopause, with vasomotor symptoms, sexual dysfunction, accelerated bone loss, and potential long‐term ...
Agnaldo Lopes da Silva Filho   +7 more
wiley   +1 more source

AI‐Powered Virtual Patients in Health Professions Education: Learner Engagement and Knowledge Application

open access: yesJournal of Dental Education, EarlyView.
ABSTRACT Purpose/Objectives Immersive educational technologies, including applications of artificial intelligence in education (AIED), are increasingly used to develop clinical skills in health professions education. This study evaluated the feasibility and perceived value of integrating an artificial intelligence (AI)‐enabled virtual patient platform ...
Jeffrey J. Borckardt   +6 more
wiley   +1 more source

Painful stimulation of the temple during optokinetic stimulation triggers migraine-like attacks in migraine sufferers [PDF]

open access: yes, 2005
To determine whether motion sickness induced by optokinetic stimulation would trigger migraine-like attacks, 27 migraine sufferers and 23 controls attended the laboratory up to three times at intervals of at least 3 weeks.
Granston, A., Drummond, P.D.
core  

Home - About - Disclaimer - Privacy